These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9241318)

  • 21. The sensitivity of the trivariate analysis using maternal serum alpha-feto protein, human chorionic gonadotrophin and maternal age in screening for fetal aneuploidy in mothers above the age of 35.
    Anandakumar C; Chew S; Wong YC; Goh VH; Tain CF; Ratnam SS
    J Perinat Med; 1999; 27(3):178-82. PubMed ID: 10503178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cost-effectiveness of universal screening in pregnancy for subclinical hypothyroidism.
    Thung SF; Funai EF; Grobman WA
    Am J Obstet Gynecol; 2009 Mar; 200(3):267.e1-7. PubMed ID: 19114278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal serum alpha-fetoprotein level during pregnancy and isolated cryptorchidism in male offspring.
    Boyd HA; Myrup C; Wohlfahrt J; Westergaard T; Nørgaard-Pedersen B; Melbye M
    Am J Epidemiol; 2006 Sep; 164(5):478-86. PubMed ID: 16790515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of the radioimmunoassay of alpha-fetoprotein in obstetric diagnosis. II. Behavior of the serum level of AFP in normal regnancy].
    Altobelli L; Ramponi M; Gori G; de Aloysio D; Guerresi E
    Riv Ital Ginecol; 1976; 57(4-6):245-61. PubMed ID: 79209
    [No Abstract]   [Full Text] [Related]  

  • 25. Routine assessment of amniotic fluid alpha-Fetoprotein in early second-trimester amniocentesis is no longer justified.
    Widlund KF; Gottvall T
    Acta Obstet Gynecol Scand; 2007; 86(2):167-71. PubMed ID: 17364279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of isotopic and nonisotopic immunoassays for the measurement of alpha-fetoprotein.
    Coli A; Ferdeghini M; Russo R; Pilo A; Zucchelli GC; Prontera C; Serra S
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):27-9. PubMed ID: 2480417
    [No Abstract]   [Full Text] [Related]  

  • 27. Cost-effectiveness analysis of prenatal diagnosis intervention for Down's syndrome in China.
    Chen Y; Qian X; Li J; Zhang J; Chu A; Schweitzer SO
    Int J Technol Assess Health Care; 2007; 23(1):138-45. PubMed ID: 17234028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amniotic fluid human chorionic gonadotrophin and alpha-fetoprotein levels in pregnancies conceived after assisted reproduction.
    Hui PW; Lam YH; Tang MH; Ng EH; Yeung WS; Ho PC
    Prenat Diagn; 2003 Jun; 23(6):484-7. PubMed ID: 12813762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal serum alpha-fetoprotein in normal and complicated pregnancies.
    Soong YK; Yen JK; Chen HF
    Taiwan Yi Xue Hui Za Zhi; 1984 Nov; 83(11):1113-9. PubMed ID: 6084702
    [No Abstract]   [Full Text] [Related]  

  • 30. Intrahepatic cholestasis of pregnancy has no effect on maternal serum second trimester alpha-fetoprotein and hCG.
    Eloranta ML; Heinonen S; Kirkinen P
    Acta Obstet Gynecol Scand; 2000 Jul; 79(7):548-52. PubMed ID: 10929953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down syndrome: prenatal risk assessment and diagnosis.
    Newberger DS
    Am Fam Physician; 2000 Aug; 62(4):825-32, 837-8. PubMed ID: 10969860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent mixed germ cell tumor of the ovary manifest as an unexplained elevated maternal serum alpha-fetoprotein.
    Wax JR; Segna RA
    J Matern Fetal Med; 1997; 6(6):338-40. PubMed ID: 9438217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Radioimmunologic determination of alpha fetoprotein in high risk pregnancies].
    Arnold HP; Rauskolb R; Jovanovic V
    Arch Gynecol; 1979 Jul; 228(1-4):200. PubMed ID: 90481
    [No Abstract]   [Full Text] [Related]  

  • 34. Follow-up of elevated maternal serum alpha-fetoprotein levels: ultrasonography only or amniocentesis?
    Whitehead N; MacMahon W; Fernhoff P; Priest J
    Am J Obstet Gynecol; 1991 Jun; 164(6 Pt 1):1688-9. PubMed ID: 1710875
    [No Abstract]   [Full Text] [Related]  

  • 35. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
    Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
    Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
    Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
    Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated maternal serum alpha-fetoprotein levels associated with breakdown in fetal-maternal-placental barrier.
    Berkeley AS; Killackey MA; Cederqvist LL
    Am J Obstet Gynecol; 1983 Aug; 146(7):859-61. PubMed ID: 6191572
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical use of a quadruple biochemical marker in the prediction of obstetric complications].
    Aranda Gallegos JE; Barrón Vallejo J; de la Luna Pérez LG; Corona de Lau QC; Kably Ambe A
    Ginecol Obstet Mex; 1999 Jan; 67():18-22. PubMed ID: 10085605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prenatal maternal blood screening for the detection of fetal chromosomal abnormalities: clinical importance of the rate of false positives].
    Alvarez-Nava F; Soto M; Padrón T; Morales A; Villalobos D; Rojas de Atencio A; Prieto M; Martínez MC
    Invest Clin; 2003 Sep; 44(3):195-207. PubMed ID: 14552058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal and fetal serum transformed alpha-fetoprotein levels in normal pregnancy.
    González-Bugatto F; Foncubierta E; Bailén Mde L; Illanes S; Hervías-Vivancos B; Bartha JL
    J Obstet Gynaecol Res; 2009 Apr; 35(2):271-6. PubMed ID: 19453690
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.